“32 Year-old with DKA in the Setting of COVID 19 Infection”
Olha Duchon, MD, Endocrinology Fellow
1. Discuss EuDKA and its etiologies.
2. Euglycemic DKA in the setting of SGLT2 inhibitors use.
3. DKA treatment in the time of pandemic (limited resources).
“The Impact of ADHD on Adolescent Management of T1DM”
Hayley Goldenthal, MA, MS, Psychology Extern, Health & Wellness Team
1. Review signs and symptoms of ADHD and the association of ADHD with T1DM.
2. Describe the impact of ADHD symptomatology on diabetes management including adherence.
3. Discuss how the medical team may support and intervene with patients who have dual diagnosis of T1DM and ADHD.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation